The University of Tennessee Graduate School of Medicine, Knoxville

The Department of Medicine

Wahid T. Hanna, MD

Division of Hematology and Oncology

Clinical Focus

General Oncology, Thrombosis and Hemostasis


Medical School
Ain-Shams University Hospital, Egypt, 1969

Registrar Hematology, St. Catherine's Hospital, England, 1975; Registrar Hematology, Walton Hospital, England, 1976

Senior Registrar Hematology, Liverpool Royal Infirmary, Liverpool University Hospital, England, 1977
Second Year Fellow in Hematology/Medical Oncology, University of Tennessee Medical Center, 1978
Special Fellow in Oncology, University of Tennessee Medical Center, 1979


Diplomate of the International Board of Clinical and Applied Thrombosis, Hemostasis and Vascular Medicine

Professional Affiliations

World Federation of Hemophilia
International Society on Thrombosis and Hemostasis
Knoxville Academy of Medicine
Tennessee Medical Association
American Heart Association
Fellow Council on Arteriosclerosis
Thrombosis and Vascular Biology
Fellow, International Society of Hematology
American Medical Association
American Society of Hematology
International Society of Experimental Hematology
Southern Medical Association
New York Academy of Sciences, Founding Member
Hemophilia Research Society
American Society of Clinical Oncology
National Hemophilia Foundation
American Federation for Medical Research
Southern Association for Oncology
American Association for the Advancement of Science

Current Publications

Hart LL, Ferrarotto R, Andric ZG, Beck JT, Subramanian J, Radosavljevic DZ, Zaric B, Hanna WT, Aljumaily R, Owonikoko TK, Verhoeven D, Xiao J, Morris SR, Antal JM, Hussein MA.
Myelopreservation with Trilaciclib in patients receiving Topotecan for small cell lung cancer: Results from a randomized, double-blind, placebo-controlled phase II study. Advances in Therapy. 2020 Oct 29. [Epub ahead of print]

Roschewski M, Dunleavy K, Abramson JS, Powell BL, Link BK, Patel P, Bierman PJ, Jagadeesh D, Mitsuyasu RT, Peace D, Watson PR, Hanna WT, Melani C, Lucas AN, Steinberg SM, Pittaluga S, Jaffe ES, Friedberg JW, Kahl BS, Little RF, Bartlett NL, Fanale MA, Noy.
Multicenter study of risk-adapted therapy with dose-adjusted EPOCH-R in adults with untreated Burkitt lymphoma. Journal of Clinical Oncology. 2020 May 26:JCO2000303. [Epub ahead of print]

Weiss JM, Csoszi T, Maglakelidze M, Hoyer RJ, Beck JT, Gomez MD, Lowczak A, Aljumaily R, Lima CMR, Boccia RV, Hanna W, Nikolinakos P, Chiu VK, Owonikoko TK, Schuster SR, Hussein MA, Richards DA, Sawrycki P, Bulat I, Hamm JT, Hart LL, Adler S, Antal JM, Lai AY, Sorrentino JA, Yang Z, Malik RK, Morris SR, Roberts PJ, Dragnev KH.
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small cell lung cancer receiving 1st-line chemotherapy: A Phase 1b/randomized Phase 2 trial. Annals of Oncology. 2019 Aug 27. [Epub ahead of print]

Bekaii-Saab T, Starodub A, El-Rayes B, O'Neil B, Shahda S, Ciombor K, Noonan A, Hanna W, Sehdev A, Shaib W, Mikhail S, Neki A, Oh C, Li YZ, Li W, Borodyansky L, Li CJ.
LBA-002A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts). Annals of Oncology. 2017 Jun 1;28(suppl_3).

Current Presentations

Baveja S, Turner JF, Hanna WH, Dudney TD, Sneed G, Huang H, Hohenforst-Schmidt W, Zarogoulidis P.. Multilobar metastatic adenocarcinoma: A case report and review of the literature of digital papillary eccrine adenocarcinoma presenting with hypoxic respiratory failure. Presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer (Invited Lecture); 2018 Sep 26; Toronto, Canada.

Wall JS, Foster JS, Koul R, Williams A, Martin EB, Richey T, Stuckey A, Macy S, Lands R, Hanna W, Kennel SJ. A novel bifunctional peptide-FC-fusion construct for immunotherapy of visceral amyloidosis. Presented at 58th American Society of Hematology Annual Meeting and Exposition; 2016 Dec 3-6; San Diego, CA.

Martin EB, Williams A, Heidel RE, Adams S, Lands R, Hanna W, Kennel SJ, Wall JS. A method to predict the amyloidogenic propensity of light chain proteins by measuring binding to synthetic amyloid fibrils. Presented at 58th American Society of Hematology Annual Meeting and Exposition; 2016 Dec 3-6; San Diego, CA.


Support The University of Tennessee Graduate School of Medicine

The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290

Copyright © 2019